News
Biotronik announced the first U.S. implant of their Pulsar-18 self expanding stent in the BIOFLEX-I IDE clinical trial. Carlos Mena of Yale University Medical Center performed the procedure.
January 16, 2013
News
Covidien announced the completion of enrollment in its DEFINITIVE AR (anti-restenosis) study. As the third study in the DEFINITIVE trial series, this randomized pilot is designed to address the challenge of preventing restenosis (re-narrowing of a blood vessel following treatment), a common occurrence in patients with peripheral artery disease (PAD).
January 16, 2013
Feature
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the U.S. market for diagnostic imaging equipment servicing will grow slowly to a value of just over $2.78 billion by 2017. Increases in diagnostic imaging system sales and the installed base will be counterbal
January 14, 2013Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
Technology
McKesson released its Cardiology 13.0 system, which offers a single database solution for cardiac and peripheral catheterization, hemodynamic monitoring, electrophysiology (EP), echocardiography, vascular ultrasound, nuclear cardiology and electrocardiogram (ECG), ECG stress and Holter management. Data entered at any point-of-care flows into the electronic health record (EHR) without the need for potentially cumbersome interfaces or redundant documentation. This latest release is designed to boost clinical efficiencies and reduce operational costs.
January 14, 2013
Technology
April 27, 2012 — GE Healthcare, a unit of General Electric Company, announced the U.S. Food and Drug Administration (FDA) clearance and availability of the latest version of its Vivid E9 cardiovascular ultrasound system. The Vivid E9 Breakthrough 2012 (BT12) includes a 4-D transducer for transesophageal echocardiography (TEE) and also provides innovative tools designed to help improve workflow efficiency through simplified image acquisition, intuitive navigation and advanced, yet easy to use, quantification.
January 14, 2013
Feature
The Detroit Medical Center (DMC) announced that a team of heart specialists at its Cardiovascular Institute (CVI) has successfully conducted the Midwest's first-ever "robotic-assisted" coronary revascularization to relieve heart artery blockages. The successful implementation of the pioneering new treatment procedure — unique in Michigan and so far performed at only three institutions in the United States — means that DMC heart care patients now have access to the world's most advanced treatment method for relieving blockages in heart arteries, said CVI President Theodore L. Schreiber, M.D.
January 14, 2013Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
January 11, 2013 — Guided Interventions LLC, a startup company developing new, easier to use fractional flow reserve (FFR) a product to help cardiologists better assess the physiological impact of coronary artery blockages, has received a $250,000 investment commitment from nonprofit venture development organization JumpStart Inc.
January 11, 2013
News
August 20, 2012 — Zoll Medical Corp., a manufacturer of medical devices and related software solutions, announced that physicians at all of the 17 “Honor Roll” hospitals and all of the 50 “Best Cardiology and Heart Surgery” hospitals designated by U.S. News and World Report for 2012-2013 have prescribed the Zoll LifeVest Wearable Defibrillator for patients.
January 10, 2013
Technology
Toshiba has unveiled a 640-slice computed tomography (CT) scanner at the 2012 annual meeting of the Radiological Society of North America (RSNA). The Aquilion One Vision Edition is equipped with a gantry rotation of 0.275 seconds, a 100 kw generator and 320 detector rows (640 unique slices) covering 16 cm in a single rotation, with the industry’s thinnest slices at 500 microns (0.5 mm).
January 10, 2013Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024Technology
Zoll’s RescueNet 12-Lead is a free and versatile transmission system that allows healthcare providers to receive and ...
January 09, 2013
News
Angioslide announced the closing of $6.3 million financing led by new investor TriVentures. In addition Biostar joined returning investors Viola Partners, Agate and XT Investments to complete the round.
January 08, 2013
News
The results of a recent study presented yesterday at the American Heart Association Scientific Sessions 2012 conference in Los Angeles showed that a high-quality single-lead ECG can be quickly and easily recorded using an iPhone with the AliveCor medical device and application to diagnose atrial fibrillation (AF).
January 08, 2013Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
CardiAQValve Technologies Inc. received $37.3 million in funding in its second round of equity financing. OrbiMed led the round and was joined by Versant Ventures, Advent Life Sciences and existing investors. The funding, which incorporates conversion of a 2011 bridge financing, will be used to further validate the company’s transcatheter mitral valve implantation (TMVI) technology and is expected to carry the company through its feasibility and CE mark clinical trials. Concurrent with the financing, David Bonita, M.D., and Vince Burgess have joined the board of directors representing OrbiMed.
January 08, 2013
News
Spectranetics Corp. announced an agreement to purchase the assets of Upstream Peripheral Technologies Ltd., an affiliate of Aran Research Development and Prototypes Ltd. Included in the acquisition are unique technologies that expand Spectranetics' vascular intervention portfolio. A full launch in the United States and Europe will occur in February 2013.
January 08, 2013
Feature
Abbott announced the initiation of the ABSORB III clinical trial in patients in the United States. The randomized controlled trial will enroll about 2,250 patients and compare the performance of Abbott's drug-eluting Absorb boresorbable vascular scaffold (BVS) device to the company's Xience family of drug-eluting stents.
January 08, 2013